The relationship between autism and the gut microbiome has become one of the most active areas of research connecting gastrointestinal health, immunology, and neuroscience.
Why do children with autism frequently experience digestive problems? How does the gut microbiome influence gastrointestinal symptoms, and what opportunities could emerging postbiotic technologies offer?
Several studies published in October 2026 provide new insights into these questions.
Their findings highlight connections between gut bacteria, feeding behavior, digestive comfort, and the complex communication network known as the gut–immune–brain axis.
Why Gut Health Matters in Autism
Gastrointestinal difficulties are common among children with autism spectrum disorder (ASD).
Frequently reported problems include:
- Constipation and irregular bowel movements.
- Abdominal bloating and excessive gas.
- Abdominal pain and discomfort.
- Diarrhea.
- Food selectivity and feeding difficulties.
- Sleep disturbances associated with digestive discomfort.
For children who have difficulty communicating physical sensations, identifying gastrointestinal discomfort can be particularly challenging.
Pain or digestive problems may sometimes appear as increased irritability, restlessness, changes in behavior, or disrupted sleep.
This makes digestive health an important component of overall well-being.
Researchers are increasingly investigating whether differences in the intestinal microbiome help explain some of these gastrointestinal symptoms.
New 2026 Study: Gut Microbiome and Feeding Behavior in 140 Children
On October 23, 2026, the Journal of Clinical Medicine Research published a study examining gut microbiota, feeding difficulties, and markers associated with intestinal barrier function in children with autism.
The study included:
- 70 children with autism, aged 3–12.
- 70 typically developing children in a comparison group.
Researchers analyzed selected intestinal bacterial populations, feeding and mealtime behavior, and fecal markers associated with the intestinal environment.
What Did the Researchers Discover?
1. Differences in beneficial bacterial populations
Children with ASD demonstrated lower levels of certain bacterial groups, including Bifidobacterium, Lactobacillus, and Prevotella.
These microorganisms have attracted scientific interest because of their roles in the intestinal ecosystem.
2. Changes in other microbial populations
Researchers also identified differences involving other bacteria, including increased levels of Clostridioides difficile.
3. Higher levels of selected intestinal markers
The ASD group showed higher fecal zonulin and calprotectin levels than the comparison group.
These findings contributed to the researchers’ interest in potential relationships between microbial composition, intestinal barrier function, and gastrointestinal health.
An Important Connection With Feeding Difficulties
One particularly interesting finding involved the relationship between intestinal bacteria and feeding behavior.
Within the ASD group, lower Bifidobacterium levels were associated with more pronounced feeding difficulties.
Higher Clostridioides difficile levels were also associated with greater difficulties during mealtimes.
Interestingly, these feeding problems did not show a significant relationship with overall autism severity in the study.
The results suggest that gut microbial patterns may be linked to specific feeding challenges rather than simply reflecting the severity of autism symptoms.
This creates an interesting research opportunity focused on the intestinal environment and digestive comfort.
Another October 2026 Study: Gut Bacteria and Digestive Symptoms
A separate study published on October 14, 2026, in Pediatric Research examined the relationship between gut microbiota and gastrointestinal symptoms in children with ASD.
Researchers identified differences in microbial composition and diversity, along with associations between particular bacterial groups and symptoms such as:
- Flatulence.
- Abdominal discomfort.
- Changes in stool characteristics.
- Diarrhea.
- Nighttime awakening.
The findings offer further evidence that intestinal microbial patterns may be related to gastrointestinal experiences in children with autism.
The study did not find evidence of elevated intestinal inflammation across the biomarkers examined, illustrating the complexity of these biological relationships.
Together, the October studies reinforce growing scientific interest in the role of the intestinal microbiome in digestive health among children with ASD.
The Gut–Immune–Brain Axis: A New Research Direction
On October 21, 2026, Microbiome Research Reports published an article examining the interaction between the gut microbiome, immune system, and brain in autism.
This interconnected communication network is commonly described as the gut–immune–brain axis.
Gut microorganisms interact with the intestinal environment and participate in biological processes involving microbial metabolites, cellular signaling, and immune responses.
Researchers are exploring how these processes may relate to nervous system function.
Of particular interest are microbial structures and biologically active components that can interact with immune pathways.
This growing field is expanding the understanding of the intestinal microbiome beyond digestion alone.
Why Are Researchers Interested in Postbiotics?
For years, probiotics—preparations containing live microorganisms—have attracted attention as a potential approach to supporting intestinal microbial balance.
A newer field focuses on postbiotics, which are preparations of inanimate microorganisms and/or their components that provide a health benefit.
Unlike conventional probiotics, postbiotics do not depend on maintaining bacterial viability during manufacturing, storage, or consumption.
This creates opportunities to develop standardized microbial preparations.
Researchers are investigating postbiotic approaches in several areas:
- Supporting a balanced intestinal environment.
- Studying interactions with intestinal barrier function.
- Exploring immune regulatory mechanisms.
- Supporting digestive comfort without introducing live bacterial cultures.
These possibilities are particularly interesting in the context of sensitive gastrointestinal systems.
Learn more about the differences between the two approaches in our article Postbiotics vs. Probiotics: Why Postbiotics Are the Next Generation.
What Do Clinical Studies of Postbiotics Show?
In September 2026, Frontiers in Nutrition published a randomized, double-blind, placebo-controlled trial investigating beLP1, a heat-inactivated preparation of Lactiplantibacillus plantarum.
The study enrolled 140 adults with excess body weight and ongoing gastrointestinal discomfort.
Participants received postbiotic supplementation or placebo for 84 days.
The study reported several encouraging outcomes among participants receiving beLP1:
- Reduced overall gastrointestinal symptom severity.
- Improvements in abdominal pain.
- Better digestive comfort.
- Lower perceived stress.
- Favorable changes in selected gut bacterial populations.
The findings are particularly interesting because these changes occurred without introducing living probiotic microorganisms.
The research contributes to a growing scientific foundation for developing standardized postbiotic formulations focused on digestive health.
For families interested in the relationship between autism and gastrointestinal well-being, this broader direction of postbiotic research is worth following.
Read our detailed clinical research overview: Postbiotics for Gut Health: What Clinical Studies Reveal.
NBH Postbiotic Pro: A Three-Component Approach to Gut Health
Modern research into the gut microbiome, intestinal barrier function, and immune regulation helped shape the development of NBH Postbiotic Pro.
Developed by NBHemp, this three-component postbiotic formula combines:
ES1 + beLP1 + pAkk11
The components were selected to represent complementary directions in postbiotic research.
The formula focuses on three priorities.
1. Supporting the Gut Microbial Environment
Maintaining a balanced intestinal environment is an important consideration for people with sensitive digestive systems.
2. Supporting Intestinal Barrier Function
The intestinal barrier plays a central role in interactions between intestinal contents, microbial structures, and the body’s internal environment.
3. Supporting Normal Immune Regulation
The emerging gut–immune–brain research field highlights the importance of communication between microorganisms and immune pathways.
These principles are reflected in the development concept behind:
NBH Postbiotic Pro — GUT BARRIER + IMMUNE CALM
The formulation was developed with particular attention to people with sensitive digestion, including the gastrointestinal challenges that families of children with autism and epilepsy may encounter.
As research into microbial components and intestinal health expands, multi-component postbiotic formulations offer an increasingly interesting direction for further investigation.
How Gut Health Can Affect Everyday Well-Being
Digestive comfort matters far beyond the process of food digestion.
For people experiencing recurring abdominal pain, constipation, bloating, or other gastrointestinal symptoms, improved digestive well-being can make everyday activities more comfortable.
This is especially relevant for children who may have difficulty describing pain or discomfort.
Identifying gastrointestinal problems and understanding their possible relationship with the intestinal microbiome can help guide research and discussions about digestive support.
Conclusion
Autism and the gut microbiome represent an important area of research connecting gastroenterology, immunology, and neuroscience.
Studies published in October 2026 identified meaningful relationships between intestinal microbial patterns, feeding difficulties, and gastrointestinal symptoms in children with ASD.
At the same time, researchers continue to investigate the gut–immune–brain axis and the potential role of microbial components in intestinal health.
These discoveries provide a promising scientific framework for the continued development of postbiotic technologies.
NBH Postbiotic Pro represents this approach through a combination of three selected postbiotic components designed around microbiome support, intestinal barrier function, and normal immune regulation.
Scientific References
1. Ali WH, et al. (2026).
Targeted Quantitative Polymerase Chain Reaction Analysis of Gut Microbiota and Its Association With Feeding and Mealtime Behavior and Intestinal Permeability in Children With Autism Spectrum Disorder.
Journal of Clinical Medicine Research, 18(10), 759–769.
2. Harne V, et al. (2026).
Gut microbiota are linked to gastrointestinal symptoms and behavioral changes but not inflammation in autism spectrum disorder: a cross-sectional analysis.
Pediatric Research.
3. Park JC, Im S-H. (2026).
New insights into the gut-immune-brain axis: immune mechanisms and therapeutic targets for autism spectrum disorder.
Microbiome Research Reports, 5:26.
https://doi.org/10.20517/mrr.2026.48
4. Manoharan RK, et al. (2026).
Gut health and microbiome modulation by the heat-killed postbiotic beLP1® in adults with excess weight: a randomized, placebo-controlled trial.
Frontiers in Nutrition, 13:1919277.
https://doi.org/10.3389/fnut.2026.1919277
5. Salminen S, et al. (2021).
The International Scientific Association of Probiotics and Prebiotics (ISAPP) consensus statement on the definition and scope of postbiotics.
Nature Reviews Gastroenterology & Hepatology.
Leave a Reply